These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 12045833
1. Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease. Castro RR, Porphirio G, Serra SM, Nóbrega AC. Braz J Med Biol Res; 2002 Jun; 35(6):685-9. PubMed ID: 12045833 [Abstract] [Full Text] [Related]
2. Reduction of QTc interval dispersion. Potential mechanism of cardiac protection of pyridostigmine bromide. Castro RR, Serra SM, Nóbrega AC. Arq Bras Cardiol; 2000 Sep; 75(3):205-13. PubMed ID: 11018806 [Abstract] [Full Text] [Related]
9. Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine. Serra SM, Costa RV, Bastos BG, Bousquet Santos K, Ramalho SH, da Nóbrega AC. Arq Bras Cardiol; 2001 Apr; 76(4):279-84. PubMed ID: 11323731 [Abstract] [Full Text] [Related]
10. Pyridostigmine reduces QTc interval during recovery from maximal exercise in ischemic heart disease. Castro RR, Serra SM, Porphirio G, Mendes FS, Oliveira LP, Nóbrega AC. Int J Cardiol; 2006 Feb 08; 107(1):138-9. PubMed ID: 16337518 [Abstract] [Full Text] [Related]
11. Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects. Sant'anna ID, de Sousa EB, de Moraes AV, Loures DL, Mesquita ET, da Nóbrega AC. Clin Sci (Lond); 2003 Aug 08; 105(2):161-5. PubMed ID: 12627998 [Abstract] [Full Text] [Related]
13. Resting and reflex heart rate responses during cholinergic stimulation with pyridostigmine in humans. Nóbrega AC, Carvalho AC, Bastos BG. Braz J Med Biol Res; 1996 Nov 08; 29(11):1461-5. PubMed ID: 9196546 [Abstract] [Full Text] [Related]
14. Cholinesterase inhibition reduces arrhythmias in asymptomatic Chagas disease. Castro RRT, Porphirio G, Xavier SS, Moraes RS, Ferlin EL, Ribeiro JP, da Nóbrega ACL. Cardiovasc Ther; 2017 Oct 08; 35(5):. PubMed ID: 28715142 [Abstract] [Full Text] [Related]
15. Cholinergic stimulation with pyridostigmine, hemodynamic and echocardiographic analysis in healthy subjects. de Pontes PV, Bastos BG, Romeo Filho LJ, Mesquita ET, da Nóbrega AC. Arq Bras Cardiol; 1999 Mar 08; 72(3):297-306. PubMed ID: 10513041 [Abstract] [Full Text] [Related]
16. Subacute pyridostigmine exposure increases heart rate recovery and cardiac parasympathetic tone in rats. Bharadwaj M, Pope C, Davis M, Katz S, Cook C, Maxwell L. Clin Exp Pharmacol Physiol; 2017 Aug 08; 44(8):872-879. PubMed ID: 28440910 [Abstract] [Full Text] [Related]
17. Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure. Serra SM, Costa RV, Teixeira De Castro RR, Xavier SS, Nóbrega AC. J Card Fail; 2009 Mar 08; 15(2):124-9. PubMed ID: 19254671 [Abstract] [Full Text] [Related]
18. Acute electrophysiologic consequences of pyridostigmine inhibition of cholinesterase in humans. Zimerman LI, Liberman A, Castro RR, Ribeiro JP, Nóbrega AC. Braz J Med Biol Res; 2010 Feb 08; 43(2):211-6. PubMed ID: 20084332 [Abstract] [Full Text] [Related]
19. Modulation of the dose-dependent effects of atropine by low-dose pyridostigmine: quantification by spectral analysis of heart rate fluctuations in healthy human beings. Izraeli S, Alcalay M, Benjamini Y, Wallach-Kapon R, Tochner Z, Akselrod S. Pharmacol Biochem Behav; 1991 Jul 08; 39(3):613-7. PubMed ID: 1784590 [Abstract] [Full Text] [Related]
20. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial. Schreglmann SR, Büchele F, Sommerauer M, Epprecht L, Kägi G, Hägele-Link S, Götze O, Zimmerli L, Waldvogel D, Baumann CR. Eur J Neurol; 2017 Apr 08; 24(4):545-551. PubMed ID: 28224720 [Abstract] [Full Text] [Related] Page: [Next] [New Search]